Clinical trial of SFX-01 in patients with chronic kidney disease (CKD).
Latest Information Update: 20 Feb 2020
At a glance
- Drugs Sulforafan (Primary)
- Indications Kidney disorders
- Focus Adverse reactions
Most Recent Events
- 20 Feb 2020 New trial record
- 13 Feb 2020 According to Evgen Pharma media release, Dr. Thu Le, Professor of Medicine and Chief of the Division of Nephrology at the University of Rochester Medical Center will lead the trial.With the assistance of Evgen, Professor Le will lead the process to secure appropriate grant funding and obtain clinical trial regulatory approval.
- 13 Feb 2020 According to Evgen Pharma media release, the company and The University of Rochester School of Medicine and Dentistry have entered into a Memorandum of Understanding to advance SFX-01 towards a clinical trial in chronic kidney disease (CKD).